Retinal and choroidal thickness measurements using spectral domain optical coherence tomography in anterior and intermediate uveitis. by Géhl, Zsuzsanna et al.
Géhl et al. BMC Ophthalmology 2014, 14:103
http://www.biomedcentral.com/1471-2415/14/103RESEARCH ARTICLE Open AccessRetinal and choroidal thickness measurements
using spectral domain optical coherence
tomography in anterior and intermediate uveitis
Zsuzsanna Géhl*, Kinga Kulcsár, Huba JM Kiss, János Németh, Otto A Maneschg and Miklós D ReschAbstract
Background: Macular edema is a common cause of visual loss at uveitic patients. The aim of our study was to
investigate retinal and choroidal thickness at the macula in anterior (AU) and intermediate (IMU) uveitis and in
healthy individuals using spectral domain optical coherence tomography (SD-OCT).
Methods: Case-control study of 21 patients with AU and 23 patients with IMU and 34 age-matched healthy controls
was performed with Spectralis SD-OCT (Heidelberg Engineering, Germany). High resolution SD-OCT scans and macular
mapping were applied for automated measurement of retinal thickness. Standardized, masked manual measurement
of the choroidal thickness was performed in the center of the ETDRS fields on enhanced depth imaging (EDI) scans.
Evaluation of central retinal subfield thickness, 3 mm and 6 mm perifoveal rings was performed in the corresponding
ETDRS zones in patient groups.
Results: The mean central retinal subfield thickness was significantly higher in IMU (368.65 ± 115.88 μm, p = 0.0003),
but not significantly different in AU (290.42 ± 26.37 μm p= 0.6617) compared to that of in controls (278.55 ± 18.31 μm).
In both uveitis groups retina was significantly thicker in the 3 and 6 mm perifoveal rings than that of in controls (359 ±
15.24 μm in AU and 390.55 ± 70.90 μm in IMU vs 345,41 ± 15.28 μm in the control group, p = 0.0388 and p < 0.0001)
in the 3 mm and (313.83 ± 16.63 μm in AU and 343.33 ± 57.29 μm in IMU vs 299 ± 13.82 μm in the control group,
p = 0.0171 and p < 0.0001) in the 6 mm ring. Central choroidal thickness was 311.94 ± 60.48 μm in the control
eyes, showed no significant difference in AU (312.61 ± 90.35 μm) and IMU (303.17 ± 93.66 μm) eyes, and was also
similar at the perifoveal rings.
Conclusion: Significant topographical changes could be detected in the macula of AU and IMU patients. Retinal
thickness in the perifoveal rings was increased both in AU and IMU, but in the center only in IMU. Choroidal
thickness seems to be unaffected by uveitis, even in the presence of macular edema, at least in the early stage of
the inflammatory disease process.
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Anterior uveitis (AU) is the most common type of uveitis
(49%) and the proportion of intermediate uveitis (IMU) is
also estimated to be above the 10% threshold in referral
centers [1,2]. According to the Standardization of Uveitis
Nomenclature Working Group (SUN), in AU the primary
site of inflammation is the anterior chamber and in IMU* Correspondence: zsuzsannagehl@gmail.com
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unless otherwise stated.it is the vitreous. In the background of both types of uve-
itis numerous etiological causes are recognized [3].
Macular edema is the most common cause of perman-
ent visual loss in IMU. Nevertheless, macular edema
may occur in any type of ocular inflammation, among
others in AU as well [2,4,5]. The presence of cystoid
macular edema in AU is not uncommon, but especially
in the early inflammatory process it evolves into only
diffuse macular thickening [2,4]. Early recognition of
macular edema is important in the visual outcome. Ifd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to irreversible photoreceptor damage leading to per-
manent loss of central vision. With delayed treatment
of macular edema only limited visual recovery can be
achieved [6].
Subclinical macular edema may be easily misdiagnosed
by performing biomicroscopy, but with the help of op-
tical coherence tomography (OCT) macular edema can
be detected already in an early phase [4,5]. Recently the
introduction of the spectral-domain OCT (SD-OCT) im-
proved not only retinal image resolution, but some in-
strumental setups now allow a better visualization of the
choroid as well. The Spectralis (Heidelberg Engineering,
Heidelberg, Germany) incorporating software, with its
enhanced depth imaging (EDI) technology allows for the
good quality imaging of the choroid, permitting the
qualitative and quantitative analysis of this layer [7].
EDI-ready devices gained great significance in the detec-
tion of inflammatory processes involving the choroid.
The aim of the present study was to determine the ret-
inal and choroidal thickness in the macula in AU and
IMU patients. In AU and IMU macular edema can be a
structural complication affecting the posterior segment
[3]. Further aim of the study was to correlate retinal and
choroidal changes in uveitic macular edema.
Methods
A retrospective analysis was performed on 44 eyes of 44
consecutive uveitic patients (21 AU and 23 IMU eyes)
and 34 eyes of 34 healthy subjects, who underwent OCT
examination using Heidelberg Spectralis SD-OCT be-
tween January 2012 and January 2013 at the Department
of Ophthalmology at Semmelweis University. The study
was approved by the local Ethics Committee (ETT
TUKEB) and was conducted in accordance with the
Declaration of Helsinki. One eye per patient was selected
as the study eye. If the inflammation was bilateral, the
eye with better visualization of the choroid–scleral junc-
tion on OCT images was chosen.
Normal subjects had 20/20 best corrected visual acuity
with a refractive error level below +6.0 or -6.0 diopters,
and they did not have any ocular pathology or any oph-
thalmic surgery in the history.
Inclusion criteria of uveitic patients were: active biomi-
croscopic signs of AU or IMU. OCT examination was
performed on the first visit of the patient with newly di-
agnosed uveitis at our uveitis center, or on the first visit
of the patients with recurrence after a quiescent period.
The anatomic localization of the uveitis was established
according to SUN criteria [3]. After detailed medical his-
tory and slit lamp examination standard diagnostic work up
(laboratory examination including complete blood counts,
comprehensive metabolic panel, erythrocyte sedimentation
rate, C-reactive protein, chest x-ray), and in selected caseswith the suspect of specific etiology: QuantiFERON-TB
Gold, angiotensin-convertase enzyme, immune panel,
sacroiliacal x-ray, brain MRI, chest CT, and specific
serological assays were performed regarding herpes vi-
ruses, lues, toxoplasmosis, bartonella and borrelia.
In this series we had three patents in AU group with
rheumatological signs and HLA-B27 positivity. Either in
AU or in IMU group patients with other proved specific
and systemic etiology, and infectious origin were excluded.
Further exclusion criterion was vitreoretinal traction
or epiretinal membrane causing significant retinal distor-
tion. Uveitis was in the early period of the inflammatory
process in all patients. The OCT imaging was made at
the first visit of the first or the recurrent inflammatory
period, within 1-3 weeks, as far as possible we could tell
from the patients history. In these cases the vitreous
haze was maximum 2+ severity.
OCT acquisition and analysis protocol
All patients after pupil dilatation underwent SD-OCT im-
aging by the Spectralis (Heidelberg Engineering Germany,
Version 1.6.4.0). Images were acquired using horizontal
raster pattern scans, which were obtained via a 20 × 20-
degree (5.4 × 5.4) scan field, consisting of 49 sections.
Retinal thickness in the 9 Early Treatment Diabetic
Retinopathy Study (ETDRS) subfields was analyzed by
the RT map analysis protocol. Choroidal thickness was
measured with EDI scans, in the center of each ETDRS
subfield (Figure 1A). The central subfield (CSF) was a
region with a diameter of 1.0 mm around the fovea, and
the inner and the outer rings had diameters of 3 and
6 mm. Choroidal thickness measurement was performed
perpendicular to the RPE, going from the posterior RPE
edge to the choroid–scleral junction in the center of all
ETRDS subfields (Figure 1B). Evaluation of OCT scans
and measurement of retinal and choroidal thickness was
done by an independent and masked reader. Retinal and
choroidal thickness in all ETDRS fields was recorded. The
mean thickness of the 3 mm (average of S3, T3, N3 and I3
fields) and 6 mm (average of S6, T6, N6 and I6 fields) rings
was calculated and used for further statistical analysis.
Statistical analysis
The statistical analysis was performed using the Statis-
tica 11.0 software (Statsoft, Tulsa, OK, USA). Data distri-
bution was checked by Shapiro-Wilk’s W test, which
showed non-normally distributed data, hence nonpara-
metric tests were conducted. Kruskal-Wallis one-way
analysis of variance test was applied to compare mean
retinal and choroidal thicknesses among the three pa-
tient groups. Wilcoxon nonparametric test was the tool
for comparative evaluation between CSF and perifoveal
rings. Additionally we correlated retinal thickness to
choroidal thickness at different measurement points
Figure 1 Measurement of choroidal and retinal thickness in ETDRS fields. 1A. Demonstrates the 1, 3 and 6 mm diameter ETDRS circles
superimposed on the pseudocolor infrared image. The horisontal line shows the cross section shown on 1B,where choroidal thickness was
measured manually with the inbuilt caliper in the center of each ETDRS field. 1C shows the automatically calculated average thickness and
volume of the retina in the field.
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mean values ± standard deviation. Significance was ac-
cepted for p < 0.05. Fisher exact test was used to deter-
mine the rate of cystoid macular edema.
Receiver operating characteristic (ROC) curve was
plotted by means of the Med Calc Version 12.5.0.0 soft-
ware (Med Calc Software bvba, Ostend, Belgium), and
the cut-off value was calculated from this curve.
Results
The study involved 78 participants. They were put into a
control group (n = 34; mean age 37.4 ± 10.6 range: 23 to
67 years), an AU group (n = 21; mean age 41.2 ± 13.25
range: 21 to 73 years) and an IMU group (n = 23; mean
age 39.7 ± 13.41 range: 22 to 80 years). The mean ages of
the 3 groups were not significantly different (p = 0.5838,
Kruskal-Wallis test), thus the control group was consid-
ered age-matched.
Retinal thickness
Comparison of the mean retinal thickness at each retinal
location of AU and IMU groups to the control group are
shown in Figure 2. We also analyzed the retinal thick-
ness in perifoveal concentric rings, the results and the p
values for the differences between the groups are summa-
rized in Table 1. CSF thickness was 278.55 ± 18.31 μm for
the control group, 290.42 ± 26.37 μm for the AU and
368.65 ± 115.88 μm for the IMU group. There was no sig-
nificant difference in the CSF thickness of the AUpatients and the control group, but the CSF thickness
of the IMU patients was significantly higher than in
healthy individuals (p = 0.0001). The retina was consid-
erably thicker in both the 3 mm and the 6 mm zone, in
the AU and IMU groups alike if compared to the con-
trol group (Table 1).
Comparison of the CSF to the 3 and 6 mm perifoveal
rings in each group showed that in the AU group the
thickest region of the retina was the 3 mm ring, while it
was the thinnest in the centrum, similar to the healthy ret-
inas. In contrast to this in the IMU group the thickest part
of the retina was the 3 mm ring but it was followed by the
centrum and the thinnest region was the 6 mm ring.
ROC analysis of retinal thickness results are summa-
rized in Table 2. In the CSF analysis was not applicable
in normal-AU relation due to the lack of significant dif-
ference, while in the IMU group a substantial thickening
of the retina in CSF was found.
Regarding the morphology of the macular thickening
only one in 21 AU patients whereas 9 in 23 IMU pa-
tients had cystoid macular edema (CME), (p = 0.007,
Fisher exact test). We found central subretinal fluid
(SRF) in four patients with cystoid and in two patients
with diffuse type of macular edema - all 6 cases occurred
among the IMU patients.
Choroidal thickness
Central choroidal thickness, measured at the fovea was
311.94 ± 60.48 μm in control eyes, 312.61 ± 90.35 μm in
Figure 2 Retinal thickness in the 9 fields (Mean ± SD). C1R = central subfiled, S3R = superior quadrant of 3 mm ring, S6R = superior quadrant
of 6 mm ring, N3R = nasal quadrant of 3 mm ring, N6R = nasal quadrant of 6 mm ring, T3R = temporal quadrant of 3 mm ring, T6R = temporal
quadrant of 6 mm ring, I3R = inferior quadrant of 3 mm ring, I6R = inferior quadrant of 6 mm ring. Significant differences are detailed in Table 1.
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difference was not significant between the groups in the
centrum or in the perifoveal rings either (Kruskal-Wallis
test, p = 0.6082) (Table 1).
Comparison of the CSF to the 3 and 6 mm perifoveal
rings in each group showed that the choroidal thickness
in the 3 and 6 mm ring was not different from the CSF
in the AU and in the control groups. However, in IMU
patients both 3 mm and 6 mm rings were different from
the centrum (Wilcoxon test, p < 0.05) (Table 1).
Although in the IMU the choroidal thickness was
significantly thinner in the nasal 6 mm quadrant than
in the control group (p = 0.0364), none of the otherTable 1 Comparison of retinal thickness and choroidal thickn
Location Thickness (Mean ± SD, μm)
IMU AU N
Retina Central (CSF) 368.65 ± 115.88 290.42 ± 26.37 278
3 mm ring 390.55 ± 70.90† 359 ± 15.24† 345.
6 mm ring 343.33 ± 57.29†‡ 313.83 ± 16.63†‡ 299.0
Choroid Central 303.17 ± 93.66 312.61 ± 90.35 311
3 mm ring 289.43 ± 74.5 296.46 ± 81.11† 297
6 mm ring 261.7 ± 66.01†‡ 277.17 ± 73.23†‡ 285.1
IMU- Intermediate uveitis, AU- Anterior uveitis, CSF-Central subfield.
*- siginficant difference (Kruskal-Wallis test p < 0.05).
†Different from center (Wilcoxon test p < 0.05).
‡Different from 3 mm ring (Wilcoxon test p < 0.05).
NA = Not applicable.quadrants differed significantly from each other in
terms of thickness in the three groups (Figure 3).
Correlation of retinal and choroidal structure
No significant correlation could be demonstrated be-
tween retinal and choroidal thickness in the corre-
sponding fields, neither in the AU nor in the IMU
group (p > 0.05, Spearman rank correlation).
Discussion
Macular edema frequently accompanies AU and IMU
[2]. Our study focused on the distribution of intraretinal
and intrachoroidal fluid in AU and IMU according toess among groups with Kruskal-Wallis test
Kruskal-Wallis p value
ormal Post hoc
Normal-IMU Normal-AU IMU-AU
.55 ± 18.31 0.0003* 0.0001* 0.617 0.0407*
41 ± 15.28† 0.0004* 0.0003* 0.0388* 0.7536
9 ± 13.82†‡ <0.0001* <0.0001* 0.0171* 0.4772
.94 ± 60.48 0.6082 NA NA NA
.71 ± 55.7† 0.6666 NA NA NA
6 ± 48.82†‡ 0.1435 NA NA NA
Table 2 ROC analysis of retinal thickness values
Central (CSF) 3 mm ring 6 mm ring
Normal - IMU AUC 0.800 0.765 0.822
Specificity 91.1 100 70.6
Sensitivity 73.9 56.5 87.0
Cut-off value (μm) 297 383 304
p value <0.0001 0.0003 <0.0001
Normal - AU AUC NA 0.659 0.750
Specificity NA 82.4 66.7
Sensitivity NA 57.1 76.5
Cut-off value (μm) NA 358 306
p value NA 0.0004 0.0002
The high sensitivity and specificity of the cut-off value received as a result of the ROC-analysis in the central retinal thickness allows us to use the 297 μm as a
lower threshold for the macular edema in IMU.
AUC - Area under curve, CSF-Central subfield.
NA = Not applicable.
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based, detailed and combined evaluation of macular
edema and choroidal thickness has not been described
before in AU and IMU. The better understanding of the
correlation between retinal and choroidal involvement in
the above mentioned forms of occular inflammation
could be achieved with our study.Retinal thickness
Recent studies using OCT showed that in AU biomicros-
copically often undetected macular edema becomes visu-
alized even by means of normal retinal morphology [4,5].Figure 3 Choroidal thickness in the 9 fields (Mean ± SD). C1C = central
quadrant of 6 mm ring, N3C = nasal quadrant of 3 mm ring, N6C = nasal quad
quadrant of 6 mm ring, I3C = inferior quadrant of 3 mm ring, I6C = inferior quaIntermediate uveitis is frequently (in almost half of the
cases) accompanied by macular edema [2].
Shulman et al described that some degree of macular
edema can be found even in mild anterior uveitis [5].
Our results support this observation. In contrast to this,
as regards the CSF thickness we did not find significant
difference in the CSF thickness between individuals with
AU and age-matched controls, but the retinal thickness
was substantially higher in both the 3 mm and the
6 mm rings, retaining the retinal arrangement similar to
normal maculae [8]. Our results are in accordance with
Castellano et al., namely that in AU the retinal thicken-
ing is present typically in perifoveal ring-like distributionsubfiled, S3C = superior quadrant of 3 mm ring, S6C = superior
rant of 6 mm ring, T3C = temporal quadrant of 3 mm ring, T6C = temporal
drant of 6 mm ring. Significant differences are detailed in Table 1.
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ation in all types of AU, and that the assessment should
especially take into account the 3 mm inner ETDRS ring
values, not only CSF thickness. Interestingly in the IMU
group we also found a similar architecture, i.e. the 3 mm
ring with the highest retinal thickness, followed by the
CSF and the relative thinnest outer 6 mm ring. On the
contrary, in the AU group all three zones were signifi-
cantly thicker than in the control group. While among the
21 AU patients we found only one patient with CME, nine
patients out of 23 in the IMU group had CME. In agree-
ment with the findings of other workgroups, our data
show that the diffuse type of macular edema is much
more characteristic of AU than of CME [4].
Another OCT feature connected to IMU is SRF which
we found in six eyes and all of them were in the IMU
group. This means that SRF evolved in 13% of all uveitis
cases, in contrast to the higher percentages reported
earlier [8,9]. This result seems to be contrasting with the
observations that SRF appears in the initial phase of the
inflammatory process, but we have to emphasize that
not all patients had macular edema in our cohort [10].Choroidal thickness
Investigating the choroidal thickness in macular edema
Regatieri et al described decreased choroidal thickness
in patients with diabetic macular edema [11]. In contrast
with this result, Xu et al concluded that diabetic macular
edema did not influence the choroidal thickness, simi-
larly to our study on uveitic macular edema [12].
Despite the choroidal involvement in uveitis, there are
only few publications investigating choroidal thickness
in any type of uveitis. Posterior uveitis accompanied
mostly by thickening of choroidal layers, especially in
acute phase [13-17].
Assumably in posterior uveitis, where the choroid is
affected in inflammatory processes, choroidal thickness
is influenced by many – sometimes adverse – effects. In-
flammatory infiltration could potentially result in in-
creased thickness, whereas the diminished choroidal
circulation may result in reduced choroidal thickness.
This hypothesis is supported also by observations of
Karampelas et al. They concluded that in 21 inactive
panuveitic eyes the mean choroidal thickness was lower
and hyporeflectivity in Haller’s large vessel layer was re-
duced. They attributed these results to choroidal ische-
mia and hypoperfusion [18].
It seems, that the choroidal changes of macular region
in AU and IMU are less comparable to the results of
measuremets of posterior uveitis, where the infiltration
of the choroid is likely.
We have come to the conclusion in our control group
that the mean subfoveal choroidal thickness was in thehigher normal range, which may reflect the lower mean
age of the participants than it is in other studies.
To our best knowledge this is the first study investigat-
ing choroidal thickness in AU and IMU. We found the
choroidal thickness to be markedly thinner only in IMU
in the nasal 6 mm quadrant, none of the other quad-
rants were significantly lower in uveitis groups than the
thickness observed in normal subjects. Interestingly this
is the thinnest region of the macula in normal subjects
and it is also the only quadrant where the choroid con-
siderably attenuated. It may be either a coincident or it
could reflect to the vulnerable choroidal circulation of
the papillomacular region.
We have demonstrated significant retinal thickening in
AU and IMU, but only limited involvement of the chor-
oid could be demonstrated. Our study did not provide
sufficient evidence about the casual relationship between
the microstructural changes of the macula and the chor-
oidal structure. Our results can be interpreted in several
ways. One option is that the lack of correlation can be
attributed to the early phase of the inflammatory
process; the other explanation is that the effect of uveitic
macular edema on choroidal circulation is questionable,
similar to the effect of diabetic macular edema.
The limitations of this study are the small number of
the patients and the lack of follow up measurements in
the chronic inflammation phase. Further limitation is
the lack of available inbuilt software for the automated
measurement of choroidal thickness. Normative data-
base is not uniform, the reported normal subfoveal chor-
oidal thickness varied from 225 μm to 311 μm [19-21],
Ikuno et al have however found good interobserver re-
producibility of choroidal thickness measurement [22].
Detection of the choroid-sclera border could be im-
proved by the recently introduced swept-source optical
coherence tomography, which compared with SD-OCT
has greater sensitivity at scanning deep choroidal struc-
tures and the superficial retinal layers in the same image,
and with longer wavelength enabling better imaging of
deeper structures [23].
Conclusion
In conclusion we can say that the retinal thickness in-
creases in AU and IMU already in the early disease
process, but choroidal thickness seems to be unaffected
and not to be related to retinal thickness. In the evalu-
ation of the macular structure in AU patients it is espe-
cially recommended to analyze the OCT results of the
perifoveal region, since it provides early detection of
macular edema, even in case of normal CSFT. In IMU
cases either the center or the perifoveal macular regions
are affected by macular edema.
Our OCT findings demonstrated that in contrast with
posterior uveitis, anterior and interediate uveitis promotes
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choroid. Further development of OCT imaging technol-
ogy and multimodal imaging could provide more detailed
insight in the pathomechanism of macular strutural
changes in different types of uveitis.
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